I am the safety officer for our clinical trial and I think we should halt enrollment based on adverse events but the principal investigator disagrees and says I am being overcautious.
More people experience this than they realize.
You think the trial is too risky to keep going, but the person in charge won't stop it.
“Where Are You with Science — Biotech & Pharmaceutical R&D?”
If this sounds familiar, the Library can help you find the bigger picture.